Aclaris Therapeutics, Inc. (ACRS)
Nasdaq: ACRS · Pharmaceutical Preparations · Wayne, PA · filing with the SEC since 2012
Who runs Aclaris Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Walker Neal
CEO. First filing Oct 2015, latest Feb 6, 2026, 9 filings in all.
Officers reporting now
6
of 12 people with a filing in the last fifteen months
Directors reporting now
6
26 people on the record since 2015
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Kolbeck Roland Wilhelm | Chief Scientific Officer | Aug 2025 | Aug 4, 2026 | none |
| Hall Jesse Wayne | Chief Medical Officer | May 2025 | May 5, 2026 | none |
| Balthaser Kevin | Chief Financial Officer | Jan 2023 | Mar 3, 2026 | none |
| Walker Neal | CEO | Oct 2015 | Feb 6, 2026 | none |
| Davis Hugh M. | President and COO | Nov 2024 | Feb 6, 2026 | none |
| Loerop James | Chief Business Officer | Feb 2022 | Feb 6, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gowen Maxine | director | Jul 2019 | Jun 8, 2026 | none |
| Humphries William D. | director | Sep 2016 | Jun 8, 2026 | none |
| Mehra Anand | director | Oct 2015 | Jun 8, 2026 | none |
| Milano Vincent | director | Jan 2020 | Jun 8, 2026 | none |
| Molineaux Christopher P. | director | Oct 2015 | Jun 8, 2026 | none |
| Schiff Andrew N | director | Aug 2017 | Jun 8, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Leonard Braden Michael | 10% owner | Feb 2024 | Apr 27, 2026 | 1 · $1.4M |
Earlier names on the record33, newest filing first
Monahan Joseph · officer · last filing Mar 2025Biosion, Inc. · 10% owner · last filing Nov 2024Powell Andrew Kenneth William · director · last filing Jun 2024Reasons Bryan M. · director · last filing Jun 2024Manion Douglas J. · officer · last filing Jan 2024Cawkwell Gail · officer · last filing Jul 2023Ruffo Frank · officer · last filing Mar 2022Ali-Jackson Kamil · officer · last filing Jan 2022Foresite Capital Fund III, L.P. · 10% owner · last filing Nov 2021Foresite Capital Fund IV, L.P. · 10% owner · last filing Nov 2021Foresite Capital Fund V, L.P. · 10% owner · last filing Nov 2021Foresite Capital Management III, LLC · 10% owner · last filing Nov 2021Foresite Capital Management IV, LLC · 10% owner · last filing Nov 2021Foresite Capital Management V, LLC · 10% owner · last filing Nov 2021Tananbaum James B. · 10% owner · last filing Nov 2021Gordon David N. · officer · last filing Jul 2021Deerfield Management Company, L.P. (Series C) · 10% owner · last filing Jul 2019Deerfield Mgmt L.P. · 10% owner · last filing Jul 2019Deerfield Partners, L.P. · 10% owner · last filing Jul 2019Deerfield Special Situations Fund, L.P. · 10% owner · last filing Jul 2019Flynn James E · 10% owner · last filing Jul 2019Shanler Stuart · officer · last filing Mar 2019Fair Brett · officer · last filing Feb 2019Powala Christopher · officer · last filing Feb 2019Tullman Stephen A. · director · last filing Oct 2018Fmr LLC · 10% owner · last filing Aug 2017Bierly Rick · director · last filing Jun 2017Vivo Ventures Fund Vii, L.P. · 10% owner · last filing Mar 2017Vivo Ventures Vii Affiliates Fund, L.P. · 10% owner · last filing Mar 2017Vivo Ventures Vii, LLC · 10% owner · last filing Mar 2017Kolchinsky Peter · 10% owner · last filing Sep 2016Ra Capital Healthcare Fund LP · 10% owner · last filing Sep 2016Cha Albert · director · last filing Jul 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.